Duchenne muscular dystrophy remains an untreatable genetic disease that severely limits motility and life expectancy in affected children. The only animal model specifically reproducing the alterations in the dystrophin gene and the full spectrum of human pathology is the golden retriever dog model. Affected animals present a single mutation in intron 6, resulting in complete absence of the dystrophin protein, and early and severemuscle degeneration with nearly complete loss of motility and walking ability. Death usually occurs at about 1 year of age as a result of failure of respiratory muscles. Here we report that intra-arterial delivery of wild-type canine mesoangioblasts (vessel-associated stem cells) results in an extensive recovery of dystrophin expression, normal muscle morphology and function (confirmed by measurement of contraction force on single fibres). The outcome is a remarkable clinical amelioration and preservation of active motility. These data qualify mesoangioblasts as candidates for future stem cell therapy for Duchenne patients.

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs / Sampaolesi, Maurilio; Blot, S; D'Antona, Giuseppe; Granger, N; Tonlorenzi, R; Innocenzi, A; Mognol, P; Thibaud, Jl; Galvez, Bg; Barthélémy, I; Perani, L; Mantero, S; Guttinger, M; Pansarasa, Orietta Maria; Rinaldi, Chiara; Cusella De Angelis, Maria Gabriella; Torrente, Y; Bordignon, C; Bottinelli, Roberto; Cossu, G.. - In: NATURE. - ISSN 0028-0836. - 444:7119(2006), pp. 574-579. [10.1038/nature05282]

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

SAMPAOLESI, MAURILIO;
2006

Abstract

Duchenne muscular dystrophy remains an untreatable genetic disease that severely limits motility and life expectancy in affected children. The only animal model specifically reproducing the alterations in the dystrophin gene and the full spectrum of human pathology is the golden retriever dog model. Affected animals present a single mutation in intron 6, resulting in complete absence of the dystrophin protein, and early and severemuscle degeneration with nearly complete loss of motility and walking ability. Death usually occurs at about 1 year of age as a result of failure of respiratory muscles. Here we report that intra-arterial delivery of wild-type canine mesoangioblasts (vessel-associated stem cells) results in an extensive recovery of dystrophin expression, normal muscle morphology and function (confirmed by measurement of contraction force on single fibres). The outcome is a remarkable clinical amelioration and preservation of active motility. These data qualify mesoangioblasts as candidates for future stem cell therapy for Duchenne patients.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1581937
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 269
  • Scopus 596
  • ???jsp.display-item.citation.isi??? 551
social impact